Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib in Advanced or Metastatic Sarcoma
NCT00027716Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Oct 2001
- Primary completion
- May 2004
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in sarcoma, sponsored by Memorial Sloan Kettering Cancer Center. Started Oct 2001; status: completed.
02
Drugs
bortezomib
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT00027716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00027716.